Q1 2015

Source filing unavailable

Q1 2015 · —

Revenue—

Net Income

-$4.47M

N/M vs Q1 2014

EPS, diluted—

Operating Income-$4,182,000N/M

Operating Cash Flow-$4,265,023—

Free Cash Flowderived-$4,351,101—

Same quarter

Metric	Q1 2015	Q1 2014
Net Income	-$4.47M	-$2.51M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR